Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

The Effect of Oxytocin on Gastric Emptying

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2010 by Skane University Hospital.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Skane University Hospital
ClinicalTrials.gov Identifier:
NCT01152047
First received: June 23, 2010
Last updated: June 28, 2010
Last verified: June 2010

June 23, 2010
June 28, 2010
May 2010
October 2010   (final data collection date for primary outcome measure)
  • Satiety [ Time Frame: 2 h ] [ Designated as safety issue: No ]
    The investigator want to examine whether oxytocin leads to lower satiety scores after intake of the same volume of nutrient
  • To see if oxytocin lowers satiety [ Time Frame: 2h ] [ Designated as safety issue: No ]
    To perform a drinking satiety test twice. Once with oxytocin and once with saline. Then examine whether oxytocin decreases satiety compared to saline
Same as current
Complete list of historical versions of study NCT01152047 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
The Effect of Oxytocin on Gastric Emptying
The Effect of Oxytocin on Satiety in Patients With Dyspepsia

The investigators have seen that oxytocin lowers satiety in healthy subjects. Patients with dyspepsia suffers from decreased accommodation and increased satiety postprandially. The investigators now want to examine whether oxytocin may diminish symptoms in these patients.

Patients will come twice for a slow satiety drinking test. Once they will get saline infusion and once oxytocin 40 mU/min. At the same time they register satiety on a VAS scale.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver)
Primary Purpose: Treatment
  • Dyspepsia
  • Satiety
Drug: oxytocin
40mU/min as infusion of oxytocin
Experimental: oxytocin, satiety
Oxytocin is given as infusion to examine if this decreases satiety compared to saline during a drinking test
Intervention: Drug: oxytocin
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
30
October 2010
October 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Dyspepsia

Exclusion Criteria:

  • Age > 65 years
  • Cardiac disease
Both
18 Years to 65 Years
No
Sweden
 
NCT01152047
2009/502, 2009/502
No
Bodil Ohlsson, MD, PhD, Department of Clinical Sciences
Skane University Hospital
Not Provided
Not Provided
Skane University Hospital
June 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP